MENU
ALRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aileron Therapeutics (ALRN) Ownership - Who owns Aileron Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
41.6M
P/E Ratio
N/A
Total Cash
17.65M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALRN
Capitalization
41.6M
P/E Ratio
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash
17.7M
Total Cash/Share
0.81
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
50.2M
P/B Ratio
0.83
Cash Flow
N/A
Earnings
-2.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
108K
Current Ratio
3.30
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-29.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-49.97
Shares Held By Institutions
16.2M
Shares Outstanding - Current
21.7M
Total Liabilities
54M
Total Volume MTD
N/A
Value
1
Gain YTD
-37.020
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of stapled peptide drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com